Barclays PLC Reduces Holdings in Encompass Health Co. (NYSE:EHC)

Barclays PLC decreased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 12.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 60,878 shares of the company's stock after selling 8,959 shares during the quarter. Barclays PLC owned approximately 0.06% of Encompass Health worth $5,883,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. CIBC Asset Management Inc lifted its stake in shares of Encompass Health by 3.5% in the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock valued at $286,000 after purchasing an additional 100 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in Encompass Health by 1.3% in the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company's stock valued at $845,000 after buying an additional 123 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock worth $39,000 after buying an additional 140 shares during the period. Verdence Capital Advisors LLC raised its stake in shares of Encompass Health by 4.6% in the 3rd quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company's stock valued at $355,000 after acquiring an additional 160 shares during the period. Finally, Mount Yale Investment Advisors LLC raised its stake in shares of Encompass Health by 6.6% in the 2nd quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company's stock valued at $236,000 after acquiring an additional 170 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Analyst Ratings Changes

Several research firms recently weighed in on EHC. Barclays lifted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Royal Bank of Canada lifted their price objective on Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, October 30th. UBS Group increased their target price on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. Truist Financial reaffirmed a "buy" rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, KeyCorp increased their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus price target of $107.11.

Encompass Health Stock Up 0.7 %

NYSE:EHC traded up $0.62 during mid-day trading on Friday, hitting $94.45. The stock had a trading volume of 1,396,933 shares, compared to its average volume of 644,411. Encompass Health Co. has a twelve month low of $65.96 and a twelve month high of $104.55. The stock has a 50-day simple moving average of $99.47 and a two-hundred day simple moving average of $92.86. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $9.52 billion, a PE ratio of 22.81, a PEG ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company's revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 EPS. On average, equities research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.72%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.